{
  "schema_version": "topic_page_v1",
  "topic_page": {
    "topic_id": "topic_safety_quality_testing",
    "title": "Safety & Quality",
    "intro": {
      "what_this_topic_means": "This topic helps you browse peptides commonly associated with: Risk literacy, third-party testing, uncertainty, and why quality controls matter in research-only markets. Associations reflect search interest and categorization—not recommendations.",
      "common_misconceptions": [
        "Association with a topic is not proof of benefit.",
        "Preclinical or mechanistic evidence is not the same as proven human outcomes.",
        "Short-term biomarker changes do not guarantee long-term safety or effectiveness."
      ],
      "who_should_be_extra_cautious": [
        "Adolescents and young adults (developmental setpoints may still be calibrating)",
        "People with complex endocrine/metabolic conditions",
        "Anyone on multiple medications or with significant medical comorbidity"
      ]
    },
    "how_to_use_this_page": [
      "Topics help you browse; they do not recommend peptides.",
      "Always check status and risk score first.",
      "Human evidence and preclinical evidence are separated."
    ],
    "peptide_groups": [
      {
        "group_title": "Mapped peptides",
        "display_rule": "Alphabetical within group",
        "peptides": []
      }
    ],
    "safety_callouts": [
      {
        "title": "Adolescents and development",
        "body": "If you are under 18, treat uncertainty as part of the risk. Many compounds have little to no adolescent data, and endocrine/metabolic effects may have long-lived consequences."
      }
    ],
    "evidence_notes": [
      {
        "title": "Why evidence changes",
        "body": "Status and evidence can change as trials publish or regulators update labeling. This app aims to track updates and tie key claims to specific sources."
      },
      {
        "title": "Absence of evidence is not evidence of safety",
        "body": "Many compounds have limited human exposure data, short study durations, or outcomes that don’t capture rare or delayed harms. When uncertainty is high, the risk score reflects that explicitly."
      }
    ],
    "last_reviewed": "2026-02-14"
  }
}
